诺和诺德打出王炸!新药效果超司美格鲁肽

药视声Medispace
Feb 03

▲ 定档2026年5月29-30日苏州!精益智造·链接全球:2026中国制药产业大会重磅官宣!“我这血糖老是控制不好,体重还一路飙升,有没有一种药能同时解决这两个问题呢?”这是许多2型糖尿病患者就诊时的常见困惑。现在,代谢疾病治疗领域传来了令人振奋的消息。2026年2月2日,诺和诺德宣布其GLP-1与Amylin双靶点复方制剂CagriSema在III期REIMAGINE 2临床试验中取得积极结果...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10